Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KCNK13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TSC22D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAPPC13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL5A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3TC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V1G1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C6orf223 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KIAA2026 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BBX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMAA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RICTOR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928995 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GGT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on